Video Experimental Relacionado
Updated: May 10, 2026
05:44
The c-FOS Protein Immunohistological Detection: A Useful Tool As a Marker of Central Pathways Involved in Specific Physiological Responses In Vivo and Ex Vivo
Published on: April 25, 2016
jun-B inhibe y c-fos estimula las actividades de transformación y trans-activación de c-jun
Cell
|December 22, 1989
Resumen
El gen jun-B humano, aunque está involucrado en la transformación celular y la transactivación de AP-1, regula negativamente c-jun. Esta interacción afecta la transformación maligna y la expresión génica, revelando un complejo mecanismo regulador.
Área de la Ciencia:
- Biología Molecular Biología Molecular
- Oncología Oncología.
- Regulación genética Reglamento genético.
Sus antecedentes:
- La familia Jun de factores de transcripción, incluidos c-Jun y Jun-B, son reguladores cruciales de la expresión génica.
- Estos factores juegan un papel importante en los procesos celulares como la proliferación, la diferenciación y la apoptosis.
- La desregulación de las proteínas Jun está implicada en varios tipos de cáncer, destacando su importancia en la transformación maligna.
Objetivo del estudio:
- Para clonar y caracterizar el gen jun-B humano.
- Investigar las actividades de transformación y transactivación de jun-B.
- Para dilucidar la interacción entre jun-B y c-jun en la transformación celular y la regulación génica.
Principales métodos:
- La clonación genética y la secuenciación de la jun-B humana.
- Los ensayos de transformación celular utilizan células primarias de embriones de rata y células Rat-1A.
- Experimentos de co-transfección con oncogenes como c-Ha-ras y otros factores de transcripción (c-jun, c-fos).
- Análisis de la actividad de trans-activación de AP-1 en las células de teratocarcinoma F9.
Principales resultados:
- Jun-B exhibe una menor potencia transformadora e inmortalizadora en comparación con c-jun cuando coopera con ras.
- Jun-B por sí solo no transforma las células Rat-1A, a diferencia de c-jun.
- La coexpresión de c-jun y jun-B conduce a una disminución de la transformación y la transactivación de AP-1, lo que sugiere una regulación negativa.
- Esta interacción negativa es parcialmente reversible por el TPA (12-O-tetradecanoilforbol-13-acetato).
Conclusiones:
- Jun-B y c-jun ambos contribuyen a la trans-activación de AP-1 y la transformación maligna.
- Las interacciones entre jun-B y c-jun implican un mecanismo regulador negativo.
- Comprender estas interacciones de la proteína Jun es fundamental para descifrar las vías oncogénicas y desarrollar terapias dirigidas.
Videos de Conceptos Relacionados
02:04Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
01:30General Transcription Factors
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
02:04Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...